Results 91 to 100 of about 7,910 (224)

Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization [PDF]

, 2001
Eric J. Topol, David J. Moliterno, Howard C. Herrmann, Eric R. Powers, Cindy L. Grines, David J. Cohen, Eric A. Cohen, Michel E. Bertrand, Franz‐Josef Neumann, Gregg W. Stone, Peter M. DiBattiste, Steven J. Yakubov, Paul DeLucca, Laura A. Demopoulos   +13 more
openalex   +1 more source

Eptifibatide and 7E3, but Not Tirofiban, Inhibit α _v β ₃ Integrin–Mediated Binding of Smooth Muscle Cells to Thrombospondin and Prothrombin [PDF]

, 2001
Manjiri Lele, Mansoor Sajid, Nadeem Wajih, George A. Stouffer   +3 more
openalex   +1 more source

Effect of Intravenous Tirofiban Versus Placebo on First‐Pass Successful Reperfusion in Endovascular Stroke Thrombectomy: Insights From the RESCUE BT Randomized Clinical Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background First‐pass successful reperfusion (FPSR), defined as a successful/complete reperfusion achieved after a single thrombectomy pass, is predictive of favorable outcome in patients with acute ischemic stroke with large‐vessel occlusion.
Junjie Yuan, Hanming Ge, Zhaojun Tao, Huijie An, Qin Han, Jeffrey L. Saver, Thanh N. Nguyen, Simin Zhou, An Mao, Yuelu Wu, Raul Gomes Nogueira, Yaxuan Sun, Shunfu Jiang, Liping Wei, Xinmin Fu, Yongjie Bai, Shunyu Yang, Wei Hu, Guling Zhang, Chengde Pan, Shuai Zhang, Lin Qiao, Qiong Chen, Hongfei Sang, Zhongming Qiu, Fengfu Wu, Mingze Chang, Zhongfan Ruan   +27 more
doaj   +1 more source

Effects of glycoprotein IIb/IIIa receptor blocker (tirofiban) in acute coronary syndromes angiographic, scintigraphic and molecular biology studies [PDF]

, 2001
Amanda Rizk, AA El-Fattah, Osama Tayeh, Ahmed Elnaggar, AA El-Aziz, Mohammed Ashraf, Helmy El-Ghawaby, M Sayed, S Mokhtar   +8 more
openalex   +1 more source

FRI0209 Rate of cerebral microemboli in aps can be influenced via blockade of gpiib/iiia platelet receptor with tirofiban [PDF]

, 2001
Christof Specker, Andreas Perniok, Til Menge, M. Siebler, M. Schneider   +4 more
openalex   +1 more source

Consensus interpretation on "Expert consensus on clinical application of tirofiban in atherosclerotic cerebrovascular disease"

Chinese Journal of Contemporary Neurology and Neurosurgery, 2020
Platelet glycoprotein (GP) Ⅱ b/Ⅲ a receptor is the final common pathway of platelet aggregation and thrombosis, which can specifically and rapidly inhibit platelet aggregation. In recent years, more and more evidences support that tirofiban, a GP Ⅱ b/Ⅲ a
Xiao⁃chuan HUO, Zhong⁃rong MIAO
doaj  

PCD16: COST-EFFECTIVENESS OF TIROFIBAN PLUS HEPARIN AS COMPARED WITH HEPARIN ONLY IN TREATING UNSTABLE ANGINA

, 2000
Lei Shi, John B. Hay
openalex   +1 more source

Benefits and Safety of Tirofiban Among Acute Coronary Syndrome Patients With Mild to Moderate Renal Insufficiency [PDF]

, 2002
James L. Januzzi, Steven Snapinn, Peter M. DiBattiste, Ik‐Kyung Jang, Pierre Théroux   +4 more
openalex   +1 more source

Eptifibatide and 7E3, but Not Tirofiban, Inhibit α _v β ₃ Integrin–Mediated Binding of Smooth Muscle Cells to Thrombospondin and Prothrombin [PDF]

, 2002
Robert M. Scarborough
openalex   +1 more source

PCV21: COST-EFFECTIVENESS ANALYSIS OF ABCIXIMAB, EPTIFIBATIDE, AND TIROFIBAN IN PATIENTS WITH CORONARY SYNDROMES

, 2001
J Shahriar, JW Shaw, Daniel C. Malone
openalex   +1 more source